OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report)’s share price shot up 3% during mid-day trading on Thursday . The stock traded as high as $1.04 and last traded at $1.03. 11,243 shares were traded during trading, a decline of 91% from the average session volume of 131,748 shares. The stock had previously closed at $1.00.
Wall Street Analyst Weigh In
Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price target on shares of OKYO Pharma in a research report on Tuesday, August 27th.
Check Out Our Latest Report on OKYO
OKYO Pharma Price Performance
About OKYO Pharma
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.
Featured Articles
- Five stocks we like better than OKYO Pharma
- What are earnings reports?
- When Is the Best Time to Invest in Mutual Funds?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is NVIDIA Stock in a Correction or Consolidation?
- EV Stocks and How to Profit from Them
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
